This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Hughes, C.E.; Buttner, F.H.; Eidenmuller, B.; Caterson, B.; Bartnik, E.: Utilization of a recombinant substrate rAgg1 to study the biochemical properties of aggrecanase in cell culture systems. J. Biol. Chem., 272, 20269–20274 (1997)
Little, C.B.; Flannery, C.R.; Hughes, C.E.; Mort, J.S.; Roughley, P.J.; Dent, C.; Caterson, B.: Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitro. Biochem. J., 344, 61–68 (1999)
Sugimoto, K.; Takahashi, M.; Yamamoto, Y.; Shimada, K.; Tanzawa, K.: Identification of aggrecanase activity in medium of cartilage culture. J. Biochem., 126, 449–455 (1999)
Tortorella, M.D.; Burn, T.C.; Pratta, M.A.; Abbaszade, I.; Hollis, J.M.; Liu, R.; Rosenfeld, S.A.; Copeland, R.A.; Decicco, C.P.; Wynn, R.; Rockwell, A.; Yang, F.; Duke, J.L.; Solomon, K.; George, H.; Bruckner, R.; Nagase, H.; Itoh, Y.; Ellis, D.M.; Ross, H.; Wiswall, B.H.; Murphy, K.; Hillman, M.C., Jr.; Hollis, G.F.; Arner, E.C.; et al.: Purification and cloning of aggrecanase-1: a member of the ADAMTS family of proteins. Science, 284, 1664–1666 (1999)
Nakamura, H.; Fujii, Y.; Inoki, I.; Sugimoto, K.; Tanzawa, K.; Matsuki, H.; Miura, R.; Yamaguchi, Y.; Okada, Y.: Brevican is degraded by matrix metalloproteinases and aggrecanase-1 (ADAMTS4) at different sites. J. Biol. Chem., 275, 38885–38890 (2000)
Tortorella, M.D.; Pratta, M.; Liu, R.Q.; Austin, J.; Ross, O.H.; Abbaszade, I.; Burn, T.; Arner, E.: Sites of aggrecan cleavage by recombinant human aggrecanase-1 (ADAMTS-4). J. Biol. Chem., 275, 18566–18573 (2000)
Tortorella, M.; Pratta, M.; Liu, R.-Q.; Abbaszade, I.; Ross, H.; Burn, T.; Arner, E.: The thrombospondin motif of aggrecanase-1 (ADAMTS-4) is critical for aggrecan substrate recognition and cleavage. J. Biol. Chem., 275, 25791–25797 (2000)
Satoh, K.; Suzuki, N.; Yokota, H.: ADAMTS-4 (a disintegrin and metalloproteinase with thrombospondin motifs) is transcriptionally induced in β-amyloid treated rat astrocytes. Neurosci. Lett., 289, 177–180 (2000)
Sandy, J.D.; Westling, J.; Kenagy, R.D.; Iruela-Arispe, M.L.; Verscharen, C.; Rodriguez-Mazaneque, J.C.; Zimmermann, D.R.; Lemire, J.M.; Fischer, J.W.; Wight, T.N.; Clowes, A.W.: Versican V1 proteolysis in human aorta in vivo occurs at the Glu441-Ala442 bond, a site that is cleaved by recombinant ADAMTS-1 and ADAMTS-4. J. Biol. Chem., 276, 13372–13378 (2001)
Bluteau, G.; Conrozier, T.; Mathieu, P.; Vignon, E.; Herbage, D.; Mallein-Gerin, F.: Matrix metalloproteinase-1, −3, −13 and aggrecanase-1 and −2 are differentially expressed in experimental osteoarthritis. Biochim. Biophys. Acta, 1526, 147–158 (2001)
Flannery, C.R.; Zeng, W.; Corcoran, C.; Collins-Racie, L.A.; Chockalingam, P.S.; Hebert, T.; Mackie, S.A.; McDonagh, T.; Crawford, T.K.; Tomkinson, K.N.; La Vallie, E.R.; Morris, E.A.: Autocatalytic cleavage of ADAMTS-4 (aggrecanase-1) reveals multiple glycosaminoglycan-binding sites. J. Biol. Chem., 277, 42775–42780 (2002)
Westling, J.; Fosang, A.J.; Last, K.; Thompson, V.P.; Tomkinson, K.N.; Hebert, T.; McDonagh, T.; Collins-Racie, L.A.; La Vallie, E.R.; Morris, E.A.; Sandy, J.D.: ADAMTS4 cleaves at the aggrecanase site (Glu373-Ala374) and secondarily at the matrix metalloproteinase site (Asn341-Phe342) in the aggrecan interglobular domain. J. Biol. Chem., 277, 16059–16066 (2002)
Gao, G.; Westling, J.; Thompson, V.P.; Howell, T.D.; Gottschall, P.E.; Sandy, J.D.: Activation of the proteolytic activity of ADAMTS4 (aggrecanase-1) by C-terminal truncation. J. Biol. Chem., 277, 11034–11041 (2002)
Tortorella, M.D.; Liu, R.-Q.; Burn, T.; Newton, R.C.; Arner, E.: Characterization of human aggrecanase 2 (ADAM-TS5): substrate specificity studies and comparison with aggrecanase 1 (ADAM-TS4). Matrix Biol., 21, 499–511 (2002)
Miller, J.A.; Liu, R.-Q.; Davis, G.L.; Pratta, M.A.; Trzaskos, J.M.; Copeland, R.A.: A microplate assay specific for the enzyme aggrecanase. Anal. Biochem., 314, 260–265 (2003)
Tortorella, M.D.; Arner, E.C.; Hills, R.; Gormley, J.; Fok, K.; Pegg, L.; Munie, G.; Malfait, A.M.: ADAMTS-4 (aggrecanase-1): N-terminal activation mechanisms. Arch. Biochem. Biophys., 444, 34–44 (2005)
Chockalingam, P.S.; Zeng, W.; Morris, E.A.; Flannery, C.R.: Release of hyaluronan and hyaladherins (aggrecan G1 domain and link proteins) from articular cartilage exposed to ADAMTS-4 (aggrecanase 1) or ADAMTS-5 (aggrecanase 2). Arthritis Rheum., 50, 2839–2848 (2004)
Behera, A.K.; Hildebrand, E.; Szafranski, J.; Hung, H.H.; Grodzinsky, A.J.; Lafyatis, R.; Koch, A.E.; Kalish, R.; Perides, G.; Steere, A.C.; Hu, L.T.: Role of aggrecanase 1 in Lyme arthritis. Arthritis Rheum., 54, 3319–3329 (2006)
Liacini, A.; Sylvester, J.; Zafarullah, M.: Triptolide suppresses proinflammatory cytokine-induced matrix metalloproteinase and aggrecanase-1 gene expression in chondrocytes. Biochem. Biophys. Res. Commun., 327, 320–327 (2005)
Westling, J.; Gottschall, P.E.; Thompson, V.P.; Cockburn, A.; Perides, G.; Zimmermann, D.R.; Sandy, J.D.; ADAMTS4 (aggrecanase-1) cleaves human brain versican V2 at Glu405-Gln406 to generate glial hyaluronate binding protein. Biochem. J., 377, 787–795 (2004)
Yoshida, K.; Suzuki, Y.; Saito, A.; Fukuda, K.; Hamanishi, C.; Munakata, H.: Aggrecanase-1 (ADAMTS-4) interacts with al-antitrypsin. Biochim. Biophys. Acta, 1725, 152–159 (2005)
Miwa, H.E.; Gerken, T.A.; Huynh, T.D.; Flory, D.M.; Hering, T.M.: Mammalian expression of full-length bovine aggrecan and link protein: Formation of recombinant proteoglycan aggregates and analysis of proteolytic cleavage by ADAMTS-4 and MMP-13. Biochim. Biophys. Acta, 1760, 472–486 (2006)
Noe, M.C.; Natarajan, V.; Snow, S.L.; Mitchell, P.G.; Lopresti-Morrow, L.; Reeves, L.M.; Yocum, S.A.; Carty, T.J.; Barberia, J.A.; Sweeney, F.J.; Liras, J.L.; Vaughn, M.; Hardink, J.R.; Hawkins, J.M.; Tokar, C.: Discovery of 3,3-dimethyl-5-hydroxypipecolic hydroxamate-based inhibitors of aggrecanase and MMP-13. Bioorg. Med. Chem. Lett., 15, 2808–2811 (2005)
Xiang, J.S.; Hu, Y.; Rush, T.S.; Thomason, J.R.; Ipek, M.; Sum, P.E.; Abrous, L.; Sabatini, J.J.; Georgiadis, K.; Reifenberg, E.; Majumdar, M.; Morris, E.a.; Tam, S.: Synthesis and biological evaluation of biphenylsulfonamide carboxylate aggrecanase-1 inhibitors. Bioorg. Med. Chem. Lett., 16, 311–316 (2006)
Cross, A.K.; Haddock, G.; Stock, C.J.; Allan, S.; Surr, J.; Bunning, R.A.; Buttle, D.J.; Woodroofe, M.N.: ADAMTS-1 and-4 are up-regulated following transient middle cerebral artery occlusion in the rat and their expression is modulated by TNF in cultured astrocytes. Brain Res., 1088, 19–30 (2006)
Liu, R.; Trzaskos, J.M.: Aggrecanase: The family and its inhibitors. Curr. Med. Chem. Anti-Inflamma. Anti-Allergy, 4, 251–264 (2005)
Held-Feindt, J.; Paredes, E.B.; Bloemer, U.; Seidenbecher, C.; Stark, A.M.: Mehdorn, H.M.; Mentlein, R.: Matrix-degrading proteases ADAMTS4 and ADAMTS5 (disintegrins and metalloproteinases with thrombospondin motifs 4 and 5) are expressed in human glioblastomas. Int. J. Cancer, 118, 55–61 (2005)
Cross, A.K.; Haddock, G.; Surr, J.; Plumb, J.; Bunning, R.A.; Buttle, D.J.; Woodroofe, M.N.: Differential expression of ADAMTS-1,-4,-5 and TIMP-3 in rat spinal cord at different stages of acute experimental autoimmune encephalomyelitis. J. Autoimmun., 26, 16–23 (2006)
Gao, G.; Plaas, A.; Thompson, V.P.; Jin, S.; Zuo, F.; Sandy, J.D.: ADAMTS4 (aggrecanase-1) activation on the cell surface involves C-terminal cleavage by glycosylphosphatidyl inositol-anchored membrane type 4-matrix metal-loproteinase and binding of the activated proteinase to chondroitin sulfate and heparan sulfate on syndecan-1. J. Biol. Chem., 279, 10042–10051 (2004)
Kashiwagi, M.; Enghild, J.J.; Gendron, C.; Hughes, C.; Caterson, B.; Itoh, Y.; Nagase, H.: Altered Proteolytic Activities of ADAMTS-4 Expressed by C-terminal Processing. J. Biol. Chem., 279, 10109–10119 (2004)
Hashimoto, G.; Shimoda, M.; Okada, Y.: ADAMTS4 (aggrecanase-1) interaction with the C-terminal domain of fibronectin inhibits proteolysis of aggrecan. J. Biol. Chem., 279, 32483–32491 (2004)
Wainwright, S.D.; Bondeson, J.; Hughes, C.E.: An alternative spliced transcript of ADAMTS4 is present in human synovium from OA patients. Matrix Biol., 25, 317–320 (2006)
Cross, N.A.; Chandrasekharan, S.; Jokonya, N.; Fowles, A.; Hamdy, F.C.; Buttle, D.J.; Eaton, C.L.: The expression and regulation of ADAMTS-1,-4,-5,-9, and-15, and TIMP-3 by TGFβ1 in prostate cells: relevance to the accumulation of versican. Prostate, 63, 269–275 (2005)
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
(2009). ADAMTS-4 endopeptidase. In: Chang, A. (eds) Class 3 Hydrolases. Springer Handbook of Enzymes, vol S6. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-85705-1_32
Download citation
DOI: https://doi.org/10.1007/978-3-540-85705-1_32
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-85704-4
Online ISBN: 978-3-540-85705-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)